| Name | Walgreens #11687 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 4850 N Linder Rd, Meridian, Idaho 83646 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (208) 319-0047 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Scientists have discovered the first gene involved in regulating the optimal length of human sleep, offering a window into a key aspect of slumber, an enigmatic phenomenon that is critical to human physical and mental health.
When a medical imaging exam provides a clinical benefit, the only risk that should be considered is the exam itself rather than a patient's previous radiation exposure, according to a statement by three scientific groups representing medical physicists, radiologists, and health physicists.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the first patient has been enrolled in the second clinical trial of Glial Growth Factor 2 (GGF2). This Phase 1b single-infusion trial in people with heart failure will assess tolerability of three dose levels of GGF2, and also includes several explorative measures of efficacy.
A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate stubborn reservoirs of breast and ovarian cancer stem cells (CSCs).
› Verified 2 days ago
| NPI Number | 1093953218 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #11687 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4850 N Linder Rd, Meridian, ID 83646 |
| Phone Number | 208-319-0047 |
News Archive
Scientists have discovered the first gene involved in regulating the optimal length of human sleep, offering a window into a key aspect of slumber, an enigmatic phenomenon that is critical to human physical and mental health.
When a medical imaging exam provides a clinical benefit, the only risk that should be considered is the exam itself rather than a patient's previous radiation exposure, according to a statement by three scientific groups representing medical physicists, radiologists, and health physicists.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the first patient has been enrolled in the second clinical trial of Glial Growth Factor 2 (GGF2). This Phase 1b single-infusion trial in people with heart failure will assess tolerability of three dose levels of GGF2, and also includes several explorative measures of efficacy.
A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate stubborn reservoirs of breast and ovarian cancer stem cells (CSCs).
› Verified 2 days ago
News Archive
Scientists have discovered the first gene involved in regulating the optimal length of human sleep, offering a window into a key aspect of slumber, an enigmatic phenomenon that is critical to human physical and mental health.
When a medical imaging exam provides a clinical benefit, the only risk that should be considered is the exam itself rather than a patient's previous radiation exposure, according to a statement by three scientific groups representing medical physicists, radiologists, and health physicists.
Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the first patient has been enrolled in the second clinical trial of Glial Growth Factor 2 (GGF2). This Phase 1b single-infusion trial in people with heart failure will assess tolerability of three dose levels of GGF2, and also includes several explorative measures of efficacy.
A group of researchers, led by scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has shown that histone deacetylase (HDAC) inhibitors have the potential to eliminate stubborn reservoirs of breast and ovarian cancer stem cells (CSCs).
› Verified 2 days ago
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1200 E Watertower St, Meridian, Idaho 83642 Phone: (208) 323-6050 | |
Medicap Pharmacy Type: Community/Retail Pharmacy Location: 2790 W Cherry Ln, Meridian, Idaho 83642 Phone: (208) 288-1496 | |
Rite Aid Pharmacy 05412 Type: Medicare Supplier Location: 1600 N Main St, Meridian, Idaho 83642 Phone: (208) 888-7311 | |
Walgreens #6200 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1570 E Fairview Ave, Meridian, Idaho 83642 Phone: (208) 888-0034 | |
Fred Myer # 198 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1850 E Fairview Ave, Meridian, Idaho 83642 Phone: (208) 887-5273 |